Setting The Stage For Neurocrine's Pending PDUFA Date, Barclays Remains Positive
March 24, 2017 at 15:18 PM EDT
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is on the verge of becoming a commercial biotech company, as its PDUFA date for Ingrezza in ...